FDA approves emergency Ebola diagnostic test

The U.S. Food and Drug Administration has approved an Ebola-detecting test under the Emergency Use Authorization, according to a Newsweek report.

The LightMix Ebola Zaire rRT-PCR Test from pharmaceutical company Roche will test for the strain of Ebola behind the current outbreak, called Zaire, and can be completed in around three hours.

Although the test is not yet FDA-approved for general use, the FDA's Emergency Use Authorization will allow select laboratories in the United States and other countries to use the test for the Ebola Zaire strain until the outbreak is under better control, according to the report.



More articles on Ebola:
Confirmed Ebola case in Scotland
7 lessons learned from the Ebola outbreak
CDC lab tech exposed to Ebola showing no signs of disease

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars